Category: Radiopharmaceuticals
Global Radiopharmaceuticals
-
Diagnostic Radiopharmaceuticals & Contrast Media Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... report on global diagnostic radiopharmaceuticals & contrast media market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global ... Read More
-
Radiopharmaceuticals Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... report on global radiopharmaceuticals market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global radiopharmaceuticals market by segmenting ... Read More
-
Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030
... academic & research institute markets. The global radiopharmaceutical theranostics market is expected to reach an estimated $3.9 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market ... Read More
-
Radiopharmaceuticals Market Report by Product Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, Endocrinology, and Others), End Use (Hospitals and Clinics, Research Institutes, Diagnostic Centers), and Region 2024-2032
... size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. The radiopharmaceuticals market is primarily ... Read More
-
Nuclear Medicine Market Research Report Information by Type (Diagnosis [SPECT Radiopharmaceuticals {Tc99m, I-123, and Others} and PET Radiopharmaceuticals {F18, C11 Choline, and Others}] and Therapeutic (Alpha Emitters [Actinium-225 (Ac-225), Radium-223 (Ra-223), and Others], Beta Emitters [Yttrium-90 (Y-90), Lutetium-177 (Lu-177), and Others], and Brachytherapy Isotopes [Iodine-125 (I-125) and Others]), by Application (Neurology, Cardiology, Oncology [Prostate Cancer, Breast Cancer, Lung and Bronchus Cancer, Thyroid Cancer, Colorectal Cancer, and Others], and Others), by End User (Hospitals & Diagnostic Centers, Research Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032
... [Yttrium-90 (Y-90), Lutetium-177 (Lu-177), and Others], and Brachytherapy Isotopes [Iodine-125 (I-125) and Others]), by Application (Neurology, Cardiology, Oncology [Prostate Cancer, Breast Cancer, Lung and Bronchus Cancer, Thyroid Cancer, Colorectal Cancer, and Others], and Others), by ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market Size, Manufacturers, Opportunities and Forecast to 2030
... body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering ... Read More
-
Global Radiopharmaceuticals Market Size, Manufacturers, Opportunities and Forecast to 2030
... radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as ... Read More
-
Global Radiopharmaceuticals Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market Analysis and Forecast 2024-2030
... by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static ... Read More
-
Global Radiopharmaceuticals Market Analysis and Forecast 2024-2030
... an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in ... Read More
-
Global Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the ... Read More
-
Global Radiopharmaceuticals Market Size study, by Type (Diagnostic, Therapeutic), by Application (Cancer, Cardiology, Others), by Radioisotope (Technetium 99m, Gallium 68, Iodine I, Fluorine 18, Copper 64, Strontium 89, Yttrium 90, Radium 223, Actinium 225, Lutetium 177, Copper 67, Terbium 161, Zirconium 89, Others), by End User (Hospitals and Clinics, Medical Imaging Centers, Others) and Regional Forecasts 2022-2032
... 177, Copper 67, Terbium 161, Zirconium 89, Others), by End User (Hospitals and Clinics, Medical Imaging Centers, Others) and Regional Forecasts 2022-2032 Global Radiopharmaceuticals Market is valued approximately at USD 7.9 billion in 2023 and ... Read More
-
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
... develop assess the market, business/growth strategies, and make informed business decisions regarding radiation therapy products and services and radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and forecasts values for 2024 through ... Read More
-
Imaging Agents
... at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$7.2 Billion by the end of ... Read More
-
Global Lutetium-177(Lu-177) Market Research Report 2024
... forecast period 2024-2030. North American market for Lutetium-177(Lu-177) is estimated to increase from $ 0.68 billion in 2023 to reach $ 2.18 billion by 2030, at a CAGR of 15.79% during the forecast period of ... Read More
-
Radiopharmaceuticals
... of 11.0% over the analysis period 2023-2030. SPECT Radioisotopes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$6.2 Billion by the end of the analysis period. ... Read More
-
Global Radiopharmaceuticals Dispensing Isolator Market Growth 2024-2030
... the Radiopharmaceuticals Dispensing Isolator is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Radiopharmaceuticals Dispensing ... Read More
-
2024 Global: Nuclear Medicine/Radiopharmaceuticals Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Theranostics Market by Product (Software and Services, Radiopharmaceuticals, IVD/Biomarker Screening, Diagnostic Imaging), Application, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... was valued at $2.39 billion in 2024 and is projected to reach $5.77 billion by 2030, growing at a CAGR of 15.8% during the forecast period. Theranostics Market Overview Theranostics is a cutting-edge field of ... Read More
-
Global Diagnostic Radiopharmaceuticals Competitive Landscape Professional Research Report 2024
... gamma rays, which can be detected by medical imaging devices like gamma cameras or positron emission tomography (PET) scanners. When introduced into the body, these compounds selectively accumulate in specific organs or tissues, allowing healthcare ... Read More
-
Global Nuclear Medicine/Radiopharmaceuticals Competitive Landscape Professional Research Report 2024
... diseases. Radiopharmaceuticals are specially designed drugs that contain a radioactive material, typically a radionuclide. These radionuclides emit gamma rays or positrons, which can be detected by specialized imaging equipment such as gamma cameras or PET ... Read More
-
Global SPECT Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test ... Read More
-
Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Global Forecast 2024-2030
... to reach USD 5.48 billion in 2024, at a CAGR 6.47% to reach USD 8.00 billion by 2030. Radiopharmaceuticals are a unique category of medicinal formulations containing radioisotopes that are used in the field of ... Read More
Research Assistance
